Literature DB >> 3170111

Incidence of renal complications in Schönlein-Henoch purpura syndrome in dependence of an early administration of steroids.

J Buchanec1, V Galanda, S Beláková, M Minárik, M Zibolen.   

Abstract

Between 1976 and 1986, the authors treated 33 children with Schönlein-Henoch purpura (S-H purpura), with physiological urinary finding on admission. Twenty-three of them received prednisone already at the beginning of hospitalization, 10 were not given any prednisone at all. In patients with prednisone, nephropathy occurred only once (4.3%), in those without prednisone it occurred 5 times (50%), the incidence being thus significantly higher. Prednisone was administered in doses ranging between 1.0 and 2.5 mg/kg body mass/day, on an average for 21 days (first 10 days in the same dose, later in reduced doses). Since there is a general lack of data on the positive effect of steroids upon the prevention of nephropathies in S-H purpura, the authors recommend more thorough studies in the initial stage of the disease (before the development of nephropathies).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3170111     DOI: 10.1007/bf02549574

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  5 in total

1.  The HLA system in glomerulonephritis.

Authors:  S Nyulassy; M Buc; M Sasinka; M Pavlovic; I Slugen; V Hirschová; M Kaiserová; R Menkyna; J Stefanovic
Journal:  Clin Immunol Immunopathol       Date:  1977-05

2.  Henoch-Schönlein syndrome and selective IgA deficiency.

Authors:  A Martini; A Ravelli; L D Notarangelo; V L Burgio; A Plebani
Journal:  Arch Dis Child       Date:  1985-02       Impact factor: 3.791

3.  Similar disturbances in B cell activity and regulatory T cell function in Henoch-Schönlein purpura and systemic lupus erythematosus.

Authors:  M G Beale; G S Nash; M J Bertovich; R P MacDermott
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

4.  Prevalence of IgA2 deposits in IgA nephropathies: a clue to their pathogenesis.

Authors:  C André; F C Berthoux; F André; J Gillon; C Genin; J C Sabatier
Journal:  N Engl J Med       Date:  1980-12-04       Impact factor: 91.245

5.  Increase of IgA-bearing peripheral blood lymphocytes in children with Henoch-Schoenlein purpura.

Authors:  H Kuno-Sakai; H Sakai; Y Nomoto; I Takakura; M Kimura
Journal:  Pediatrics       Date:  1979-12       Impact factor: 7.124

  5 in total
  7 in total

1.  Effectiveness of early prednisone treatment in preventing the development of nephropathy in anaphylactoid purpura.

Authors:  F Mollica; S Li Volti; R Garozzo; G Russo
Journal:  Eur J Pediatr       Date:  1992-02       Impact factor: 3.183

2.  Early treatment with oral immunosuppressants in severe proteinuric purpura nephritis.

Authors:  Salvatore Li Volti; Giovanni Li Volti
Journal:  Pediatr Nephrol       Date:  2003-09-12       Impact factor: 3.714

Review 3.  Treatment-based literature of Henoch-Schönlein purpura nephritis in childhood.

Authors:  Marco Zaffanello; Vassilios Fanos
Journal:  Pediatr Nephrol       Date:  2008-12-09       Impact factor: 3.714

Review 4.  Effects of corticosteroid on Henoch-Schönlein purpura: a systematic review.

Authors:  Pamela F Weiss; James A Feinstein; Xianqun Luan; Jon M Burnham; Chris Feudtner
Journal:  Pediatrics       Date:  2007-11       Impact factor: 7.124

5.  Corticosteroid therapy does not prevent nephritis in Henoch-Schönlein purpura.

Authors:  F T Saulsbury
Journal:  Pediatr Nephrol       Date:  1993-02       Impact factor: 3.714

Review 6.  [Therapy of vasculitides and vasculopathies].

Authors:  C Sunderkötter; K de Groot
Journal:  Hautarzt       Date:  2008-05       Impact factor: 0.751

7.  A randomized, placebo-controlled trial of prednisone in early Henoch Schönlein Purpura [ISRCTN85109383].

Authors:  Adam M Huber; Jim King; Peter McLaine; Terry Klassen; Mary Pothos
Journal:  BMC Med       Date:  2004-04-02       Impact factor: 8.775

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.